Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
  1. 4 Option exercise See Remarks acquired 3,989 shares (option exercise)
  2. 4 Option exercise CEO acquired 7,979 shares (option exercise)
  3. 4 Option exercise See Remarks acquired 725 shares (option exercise)
  4. 4 Open-market sale See Remarks sold 564 shares at $17.06 ($9,623)
  5. 4/A Open-market sale See Remarks sold 1,076 shares at $19.06 ($20,509)
  6. 4 Option exercise See Remarks acquired 3,333 shares (option exercise)
  7. 4 Open-market sale Director sold 14,989 shares at an average $21.07 ($315,744)
  8. 4 Derivatives Options or other derivatives
  9. 4 Other disposition Director disposed of 1,000,000 shares (other)
  10. 4 Open-market sale See Remarks sold 1,534 shares at $15.47 ($23,733)
  11. 4 Open-market sale CEO sold 4,767 shares at $15.47 ($73,750)
  12. 4 Open-market sale See Remarks sold 284 shares at $15.47 ($4,394)
  13. 4 Option exercise See Remarks acquired 725 shares (option exercise)
  14. 4 Option exercise See Remarks acquired 3,989 shares (option exercise)
  15. 4 Option exercise CEO acquired 7,979 shares (option exercise)
  16. 4 Open-market sale See Remarks sold 573 shares at $19.03 ($10,906)
  17. 4 Option exercise See Remarks acquired 1,586 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 21 · 406 filings